Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
An analysis of the genomes of people from 50 ethnolinguistic groups in Africa spots 62 genes under positive selection and 3 million more genetic variants than previously documented.